Annual reports filed by certain Canadian issuers pursuant to Section 15(d) and Rule 15d-4

BUSINESS COMBINATIONS (Tables)

v3.22.1
BUSINESS COMBINATIONS (Tables)
 12 Months Ended
Dec. 31, 2021
Disclosure of detailed information about business combination [line items]  
Disclosure of detailed information about cash outflow/inflow on the acquisition [Table Text Block]
   
Fair value
  
   
TFC
    
MYM
    
Vironna
    
Pharm Yarok
    
Oranim
    
Panaxia
  
Assets
                                    
                                     
Cash and cash equivalents
  
$
 362    
$
 131    
$
 57    
$
 105    
$
 485    
$
 -  
Trade and other receivables
     3,240       2,548       259       456       1,329       -  
Indemnification asset
     8,131       -       -       -       -       -  
Biological assets
     785       63       -       -       -       -  
Inventory
     3,883       4,180       639       346       1,043       19  
Loan receivable
     8,470       2,122       -       -       -       -  
Investments
     -       -       -       -       -       2,837  
Property, plant and equipment
     15,193       6,105       210       1,145       389       88  
Derivative assets
     114       -       -       -       -       -  
Right of use assets
     15,037       630       -       -       1,312       -  
Investments
     319       -       -       -       -       -  
Intangible assets
     6,458       17,200       2,316       974       2,991       776  
                                                 
Total identifiable assets
     61,992       32,979       3,481       3,026       7,549       3,720  
                                                 
Liabilities
                                                
                                                 
Trade and other payables
     (15,196
)
     (4,442
)
     (854
)
     (1,448
)
     (1,777
)
     -  
Bank loans
     -       (915
)
     -       -       -       -  
Lease liability
     (15,037
)
     (873
)
     -       -       (1,312
)
     -  
Long term loans
     -       -       -       (1,042
)
     -       -  
Deferred tax, net
     -       (4,061
)
     (532
)
     (224
)
     (688
)
     -  
                                                 
Total identifiable liabilities
     (30,233
)
     (10,291
)
     (1,386
)
     (2,714
)
     (3,777
)
     -  
                                                 
Total identifiable assets, net
     31,759       22,688       2,095       312       3,772       3,720  
                                                 
Goodwill arising on acquisition
     67,269       39,932       2,250       4,294       2,907       3,240  
                                                 
Non-Controlling interest
     -       -       (1,026
)
     -       (1,849
)
     -  
                                                 
Total purchase price
  
$
 99,028    
$
 62,620    
$
 3,319    
$
 4,606    
$
 4,830    
$
 6,960  
Trichome Financial Corp. (“Trichome”) [Member]  
Disclosure of detailed information about business combination [line items]  
Disclosure of detailed information about business combinations [Table Text Block]
   
Proforma results for the year ended
December 31,
2021
  
       
Revenues
  
$
 55,563  
         
Net loss
  
$
 (25,372
)
MYM Nutraceuticals Inc. (“MYM”) [Member]  
Disclosure of detailed information about business combination [line items]  
Disclosure of detailed information about business combinations [Table Text Block]
 
   
Proforma results for the year ended
December 31,
2021
  
       
Revenues
  
$
61,639
  
         
Net loss
  
$
 (20,132
)
Pharm Yarok pharmacy [Member]  
Disclosure of detailed information about business combination [line items]  
Disclosure of detailed information about business combinations [Table Text Block]
 
   
Proforma results for the year ended
December 31,
2021
  
       
Revenues
  
$
58,345
  
         
Net loss
  
$
 (18,986
)
Vironna pharmacy [Member]  
Disclosure of detailed information about business combination [line items]  
Disclosure of detailed information about business combinations [Table Text Block]
 
   
Proforma profit or loss for the year ended
December 31,
2021
  
       
Revenues
  
$
56,816
  
         
Net loss
  
$
 (18,180
)
Oranim pharmacy [Member]  
Disclosure of detailed information about business combination [line items]  
Disclosure of detailed information about business combinations [Table Text Block]
 
   
Proforma profit or loss for the year ended
December 31,
2021
  
       
Net revenues
  
$
 67,589  
         
Net loss
  
$
 (17,870
)